3646 results for «574»
3646 results
Structural heart devices: what's new and how it reaches your cathlab
20 May 2026 – From EuroPCR 2026
Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...
Managing complications in STEMI: always possible?
20 May 2026 – From EuroPCR 2026
This session delves into the complexities of managing complications during STEMI interventions. Through real-world cases from Algeria, Malaysia, and Pakistan, it provides comprehensive analyses of challenging scenarios, treatment strategies, and key learnings, emphasizing the critical decision-making required to navigate complications and improve patient outcomes in high-stakes...
The dark side of calcium: complications, crashes and comebacks
20 May 2026 – From EuroPCR 2026
Focused on the formidable challenges posed by coronary calcium, this session presents three compelling cases illustrating complications, procedural crashes, and successful recoveries. Participants learn detailed approaches to treating PCI complications related to calcified lesions and develop a skillset aimed at prevention and effective management of these...
When calcium fights back: multinational insights into complex PCI and complication rescue
20 May 2026 – From EuroPCR 2026
This multinational session highlights advanced approaches to complex PCI involving heavily calcified coronary arteries. It aims to enhance mastery of contemporary calcium modification tools, reinforce decision-making skills in high-risk, complication-prone interventions, and optimize imaging-guided assessment of coronary calcium through illustrative cases from Bulgaria, Romania, and Tunisia.
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation
31 Mar 2026
Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.
Author
